EUVIMEDEUVIMED entdecken
Crossref

Is 3 Really What We Need? Relative Effectiveness of Benzathine Penicillin G and Doxycycline Treatment Regimens for Late or Unknown Duration Syphilis in 6 US Jurisdictions, 2016–2021

River A Pugsley iD, Nicole L Davis, Anna B Cope iD, Jill C Diesel iD, James Matthias, Brandi Danforth iD, Mohammad Rahman iD, Jonathan Bell, Melanie M Taylor, Felicia M T Lewis iD, Lindley A Barbee iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von River A Pugsley und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Doxycycline, Penicillin G Benzathine, Anti-Bacterial Agents, Syphilis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Centers for Disease Control and Prevention's Strengthening STD Prevention and Control for Health Departments.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Little evidence supports the need for 3 weekly benzathine penicillin G (BPG) injections to treat late or unknown duration syphilis, and completion of the regimen may be difficult. We compared treatment effectiveness of 1 versus 3 doses of BPG and doxycycline.

Methods

We conducted a retrospective cohort study using surveillance data for cases diagnosed with late or unknown duration syphilis between 2016 and 2021 from 6 jurisdictions. We categorized BPG and doxycycline treatment based on the recorded number and timing of doses received. We defined treatment effectiveness as a 4-fold decrease in nontreponemal serum titer by 24 months posttreatment and compared treatment effectiveness using log binomial regression.

Results

Among 18 027 cases eligible for inclusion, over half had 3 doses of BPG recorded (11 342, 63%); relatively few had only 1 dose recorded (1928, 11%) or received at least 28 days of doxycycline (3017, 17%). Fourfold titer decreases were observed for 75% and 80% of cases given 3 doses and 1 dose of BPG, respectively, and for the 74% given doxycycline. Treatment effectiveness was similar across all treatment dose/interval categories and remained comparable when stratified by baseline titer, pregnancy status, and human immunodeficiency virus (HIV) infection.

Conclusions

We did not observe a difference in treatment effectiveness between 1 and 3 doses of BPG, or between 3 doses of BPG and doxycycline, for late or unknown duration syphilis. Additional observational and clinical studies with more complete treatment and serologic response information are needed to confirm these findings and inform practice recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxycyclinePenicillin G BenzathineAnti-Bacterial AgentsSyphilisHumansRetrospective StudiesFemaleUnited StatesTreatment OutcomeMaleAdultMiddle Aged

Stichwörter der Autor:innen

benzathine penicillin Gbicillindoxycyclinesyphilistreatment

Substanzen

DoxycyclinePenicillin G BenzathineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Atlanta, Georgia, USA.
  • Virginia Department of Health, Division of Disease Prevention, Richmond, Virginia, USA.
  • North Carolina Division of Public Health, Raleigh, North Carolina, USA.
  • Michigan Department of Health and Human Services, Detroit, Michigan, USA.
  • Florida Department of Health, STD Section, Tallahassee, Florida, USA.
  • Louisiana Office of Public Health, STD/HIV/Hepatitis Program, New Orleans, Louisiana, USA.

ORCID-Profile: River A Pugsley, Anna B Cope, Jill C Diesel, Brandi Danforth, Mohammad Rahman, Felicia M T Lewis, Lindley A Barbee

Förderung

  • Centers for Disease Control and Prevention's Strengthening STD Prevention and Control for Health Departments

Zitieren

APA

Pugsley, R. A., Davis, N. L., Cope, A. B., Diesel, J. C., Matthias, J., Danforth, B., Rahman, M., Bell, J., Taylor, M. M., Lewis, F. M. T., & Barbee, L. A. (2026). Is 3 Really What We Need? Relative Effectiveness of Benzathine Penicillin G and Doxycycline Treatment Regimens for Late or Unknown Duration Syphilis in 6 US Jurisdictions, 2016–2021. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag099

Vancouver

Pugsley RA, Davis NL, Cope AB, Diesel JC, Matthias J, Danforth B, et al. Is 3 Really What We Need? Relative Effectiveness of Benzathine Penicillin G and Doxycycline Treatment Regimens for Late or Unknown Duration Syphilis in 6 US Jurisdictions, 2016–2021. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag099

BibTeX
@article{Pugsley2026,
  author = {Pugsley, River A and Davis, Nicole L and Cope, Anna B and Diesel, Jill C and Matthias, James and Danforth, Brandi and Rahman, Mohammad and Bell, Jonathan and Taylor, Melanie M and Lewis, Felicia M T and Barbee, Lindley A},
  title = {Is 3 Really What We Need? Relative Effectiveness of Benzathine Penicillin G and Doxycycline Treatment Regimens for Late or Unknown Duration Syphilis in 6 US Jurisdictions, 2016–2021},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag099}
}
Kostenlos starten →